See more : Primavera Capital Acquisition Corporation (PV) Income Statement Analysis – Financial Results
Complete financial analysis of Nippon Kayaku Co., Ltd. (NPKYF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nippon Kayaku Co., Ltd., a leading company in the Chemicals industry within the Basic Materials sector.
- Koninklijke Vopak N.V. (VOPKY) Income Statement Analysis – Financial Results
- MyndTec Inc. (MYTC.CN) Income Statement Analysis – Financial Results
- China XD Plastics Company Limited (CXDC) Income Statement Analysis – Financial Results
- Nantong Guosheng Intelligence Technology Group Co., Ltd. (688558.SS) Income Statement Analysis – Financial Results
- PT Trimegah Bangun Persada Tbk (NCKL.JK) Income Statement Analysis – Financial Results
Nippon Kayaku Co., Ltd. (NPKYF)
About Nippon Kayaku Co., Ltd.
Nippon Kayaku Co., Ltd., together with its subsidiaries, develops, manufactures, and sells functional chemicals, pharmaceuticals, safety systems, and agrochemicals and other products in Japan and internationally. The company's Functional and Chemical Business segment offers functional materials, such as epoxy resins, UV-curable resins, sealants for LCD and LED, maleimide resins, photoresists and insulating materials for micro electromechanical systems, and cleaning agents and chemicals. This segment also provides color materials, including inkjet colorants, dyes for textiles and papers, and materials for thermal paper; catalysts for the production of acrylic and methacrylic acid; and polarizing films, inorganic polarizers, liquid crystal display components and projector parts, and components for x-ray analysis. Its Pharmaceuticals Business segment offers anti-cancer and cancer-related drugs, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drugs and intermediates of pharmaceuticals, and drugs for diagnosing cancer, as well as GlycoMark, a product as a marker of blood sugar control used for diabetes. The company's Safety Systems Business segment provides airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Its Agrochemicals Business segment offers agricultural insecticides, herbicides, soil fumigants, and insanitary insecticides. The company also engages in real estate leasing services. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 201.79B | 1.49B | 1.52B | 1.57B | 1.62B | 1.56B | 1.58B | 1.43B | 1.45B | 161.86B | 160.07B | 154.37B | 147.12B | 148.90B | 141.03B | 134.34B | 144.93B | 148.12B | 140.03B | 134.21B | 128.02B |
| Cost of Revenue | 141.46B | 997.15M | 1.00B | 1.07B | 1.09B | 992.76M | 971.24M | 860.85M | 867.61M | 94.66B | 90.65B | 88.66B | 84.69B | 88.19B | 84.97B | 87.13B | 93.20B | 93.54B | 87.07B | 86.06B | 81.62B |
| Gross Profit | 60.33B | 496.05M | 516.57M | 502.03M | 532.42M | 566.98M | 607.34M | 567.06M | 581.94M | 67.19B | 69.42B | 65.71B | 62.43B | 60.71B | 56.06B | 47.21B | 51.72B | 54.59B | 52.95B | 48.14B | 46.40B |
| Gross Profit Ratio | 29.90% | 33.22% | 34.03% | 31.99% | 32.82% | 36.35% | 38.47% | 39.71% | 40.15% | 41.51% | 43.37% | 42.57% | 42.43% | 40.77% | 39.75% | 35.14% | 35.69% | 36.85% | 37.82% | 35.87% | 36.24% |
| Research & Development | 19.80B | 100.35M | 107.10M | 113.00M | 102.42M | 113.38M | 113.36M | 125.42M | 115.66M | 12.90B | 13.20B | 19.43B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 33.61B | 25.91B | 24.10B | 22.94B | 22.16B | 23.62B | 22.97B | 24.92B | 24.24B | 24.12B | 23.63B | 0.00 | 22.63B | 19.71B | 20.38B | 18.48B | 18.54B | 41.05B | 39.73B | 37.98B | 36.30B |
| Selling & Marketing | -439.00M | 19.34B | 18.82B | 18.19B | 18.43B | 19.62B | 19.82B | 19.30B | 20.33B | 20.77B | 21.71B | 0.00 | 20.40B | 20.17B | 19.68B | 19.36B | 20.73B | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 33.17B | 233.83M | 236.53M | 251.53M | 268.01M | 273.44M | 285.23M | 265.65M | 273.56M | 44.89B | 45.33B | 24.03B | 43.03B | 39.88B | 40.06B | 37.84B | 39.27B | 41.05B | 39.73B | 37.98B | 36.30B |
| Other Expenses | 25.00M | 531.00M | 387.00M | 434.00M | 94.00M | 177.00M | -164.00M | 237.00M | 124.56K | 269.00M | 2.00M | 0.00 | 229.00M | 870.00M | 730.00M | 629.00M | 1.16B | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 53.00B | 334.18M | 343.63M | 364.53M | 370.43M | 386.82M | 398.59M | 391.06M | 389.10M | 44.89B | 45.33B | 42.86B | 43.03B | 39.88B | 40.06B | 37.84B | 39.27B | 41.05B | 39.73B | 37.98B | 36.30B |
| Cost & Expenses | 194.45B | 1.33B | 1.35B | 1.43B | 1.46B | 1.38B | 1.37B | 1.25B | 1.26B | 139.55B | 135.98B | 131.52B | 127.72B | 128.07B | 125.03B | 124.98B | 132.47B | 134.59B | 126.81B | 124.04B | 117.92B |
| Interest Income | 843.00M | 4.04M | 1.46M | 1.53M | 2.46M | 1.88M | 959.10K | 780.76K | 462.65K | 59.00M | 68.00M | 403.33M | 83.00M | 94.00M | 148.00M | 213.00M | 191.00M | 361.00M | 0.00 | 349.00M | 312.00M |
| Interest Expense | 127.00M | 775.28K | 673.63K | 950.23K | 1.53M | 1.75M | 1.51M | 1.18M | 1.30M | 185.00M | 195.00M | 0.00 | 290.00M | 358.00M | 484.00M | 455.00M | 527.00M | 450.00M | 430.00M | 416.00M | 402.00M |
| Depreciation & Amortization | 14.40B | 14.24B | 14.10B | 13.47B | 12.58B | 12.19B | 12.21B | 11.52B | 101.79M | 10.74B | 10.44B | 10.45B | 9.93B | 9.03B | 10.03B | 10.74B | 10.87B | 8.73B | 7.71B | 7.61B | 7.14B |
| EBITDA | 21.73B | 35.75B | 35.15B | 28.67B | 30.89B | 31.91B | 33.90B | 30.96B | 32.91B | 32.99B | 34.42B | 31.25B | 29.98B | 30.70B | 26.56B | 18.10B | 22.80B | 22.79B | 21.36B | 18.43B | 17.55B |
| EBITDA Ratio | 10.77% | 18.02% | 19.02% | 16.53% | 17.17% | 18.61% | 20.50% | 19.56% | 20.33% | 22.26% | 23.10% | 20.24% | 20.38% | 21.37% | 18.83% | 14.34% | 15.73% | 15.28% | 15.25% | 13.50% | 13.71% |
| Operating Income | 7.34B | 161.88M | 172.94M | 137.49M | 161.98M | 180.16M | 208.75M | 176.00M | 192.84M | 22.30B | 24.09B | 20.80B | 19.40B | 22.79B | 16.53B | 8.53B | 11.93B | 13.90B | 13.65B | 10.52B | 10.41B |
| Operating Income Ratio | 3.64% | 10.84% | 11.39% | 8.76% | 9.98% | 11.55% | 13.22% | 12.33% | 13.30% | 13.78% | 15.05% | 13.47% | 13.19% | 15.30% | 11.72% | 6.35% | 8.23% | 9.38% | 9.75% | 7.84% | 8.13% |
| Total Other Income/Expenses | -132.00M | -533.00M | 23.53B | 17.38B | 655.00M | 21.10B | -545.00M | 2.75B | -21.49B | 1.67B | 1.30B | 2.45B | -971.00M | 478.00M | -4.90B | -2.47B | 236.00M | 71.00M | 5.41B | 238.00M | -1.16B |
| Income Before Tax | 7.21B | 157.86M | 194.70M | 158.58M | 168.04M | 192.28M | 207.44M | 201.00M | 223.75M | 23.97B | 25.39B | 23.25B | 18.43B | 21.31B | 11.10B | 6.90B | 12.69B | 13.61B | 18.63B | 10.40B | 8.94B |
| Income Before Tax Ratio | 3.57% | 10.57% | 12.82% | 10.11% | 10.36% | 12.33% | 13.14% | 14.08% | 15.44% | 14.81% | 15.86% | 15.06% | 12.53% | 14.31% | 7.87% | 5.14% | 8.75% | 9.19% | 13.30% | 7.75% | 6.98% |
| Income Tax Expense | 3.03B | 44.63M | 53.03M | 44.63M | 48.74M | 50.61M | 55.02M | 54.02M | 61.02M | 7.17B | 7.36B | 7.55B | 6.10B | 7.38B | 816.00M | 3.55B | 5.36B | 5.50B | 7.37B | 4.07B | 3.97B |
| Net Income | 4.11B | 112.79M | 141.14M | 113.79M | 118.72M | 134.18M | 145.64M | 140.31M | 153.84M | 15.65B | 16.72B | 14.54B | 11.40B | 13.00B | 9.87B | 3.72B | 6.63B | 6.61B | 9.64B | 5.32B | 3.93B |
| Net Income Ratio | 2.04% | 7.55% | 9.30% | 7.25% | 7.32% | 8.60% | 9.23% | 9.83% | 10.61% | 9.67% | 10.44% | 9.42% | 7.75% | 8.73% | 7.00% | 2.77% | 4.57% | 4.46% | 6.89% | 3.96% | 3.07% |
| EPS | 24.80 | 0.67 | 0.84 | 0.67 | 0.69 | 0.77 | 0.84 | 0.81 | 0.85 | 86.38 | 92.25 | 80.18 | 62.89 | 71.70 | 54.39 | 20.48 | 36.50 | 36.37 | 52.92 | 28.87 | 0.00 |
| EPS Diluted | 24.80 | 0.67 | 0.84 | 0.67 | 0.69 | 0.77 | 0.84 | 0.81 | 0.85 | 86.31 | 92.25 | 80.20 | 62.89 | 71.70 | 54.39 | 20.45 | 36.32 | 36.11 | 52.92 | 28.87 | 0.00 |
| Weighted Avg Shares Out | 165.88M | 167.68M | 168.94M | 170.79M | 172.60M | 173.15M | 173.15M | 173.29M | 179.96M | 181.21M | 181.23M | 181.32M | 181.29M | 181.37M | 181.48M | 181.57M | 181.65M | 181.74M | 182.18M | 184.10M | 0.00 |
| Weighted Avg Shares Out (Dil) | 165.84M | 167.68M | 168.94M | 170.79M | 172.60M | 173.15M | 173.15M | 173.29M | 179.96M | 181.36M | 181.23M | 181.29M | 181.29M | 181.37M | 181.48M | 181.81M | 182.54M | 183.05M | 182.18M | 184.10M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports